Receptor Tyrosine Kinase (KIT) Mutated Melanoma
1 clinical trials · Condition
◉ Watch Receptor Tyrosine Kinase (KIT) Mutated Melanoma
| Record | Firm | Date |
|---|---|---|
| Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study (NCT01735955) | Novartis Pharmaceuticals | 2013-03-29 |
Track Receptor Tyrosine Kinase (KIT) Mutated Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.